Abstract
The mechanism of resistance of hepatocellular carcinoma (HCC) to sorafenib is unknown and no useful predictive biomarker for sorafenib treatment has been reported. Accordingly, we established sorafenib-resistant HCC cells and investigated the underlying mechanism of resistance to sorafenib. Sorafenib-resistant cell lines were established from the HCC cell line PLC/PRF5 by cultivation under continuous exposure to increasing concentration of sorafenib. The IC50 values of the 2 resistant clones PLC/PRF5-R1 and PLC-PRF5-R2 were 9.2±0.47 μM (1.8-fold) and 25±5.1 μM (4.6-fold) respectively, which were significantly higher than that of parental PLC/PRF5 cells (5.4±0.17 μM) (p < 0.01 respectively), as determined by MTT assay. Western blot analysis of signal transduction-related proteins showed no significant differences in expression of AKT/pAKT, mTOR/pmTOR, or ERK/pERK between the 2 resistant clones versus parent cells, suggesting no activation of an alternative signal transduction pathway. Likewise, when expression of membrane transporter proteins was determined, there were no significant differences in expression levels of BSEP, MDR1, MRP2, BCRP, MRP4 and OCT1 between resistant clones and parent cells. However, the expression levels...Continue Reading
References
Dec 1, 1991·Journal of Neurosurgery·M W NaborsO M Colvin
Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S DaltonS E Salmon
Aug 2, 1989·Journal of the National Cancer Institute·S L LaiA F Gazdar
Apr 1, 1988·The Journal of Urology·Y KakehiI Pastan
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J KönigD Keppler
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·M KoolP Borst
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·A T NiesD Keppler
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Yasuhiro TadaSeiji Naito
Jun 7, 2002·Lancet·Josep M LlovetUNKNOWN Barcelona Liver Cancer Group
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael C HeinrichJonathan A Fletcher
May 1, 2004·The New England Journal of Medicine·Thomas J LynchDaniel A Haber
Jul 6, 2004·Gastroenterology·Elena TamboriniSilvana Pilotti
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Dec 21, 2006·Cancer Research·Li LiuChristopher Carter
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
May 19, 2007·World Journal of Gastroenterology : WJG·Andreas TeufelPeter-R Galle
Nov 14, 2007·Journal of Hepatology·Klaus Juergen SchmitzHideo Andreas Baba
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 20, 2008·The Lancet Oncology·Ann-Lii ChengZhongzhen Guan
Feb 21, 2009·Drugs·Gillian M Keating, Armando Santoro
Sep 3, 2010·BMC Cancer·Chien-Tsun KuanDarell D Bigner
Sep 28, 2010·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Lie LiSharyn D Baker
Jan 6, 2011·The Journal of Pharmacology and Experimental Therapeutics·Kuen-Feng ChenAnn-Lii Cheng
Sep 20, 2011·European Journal of Pharmacology·Luigi FiumeGiuseppina Di Stefano
Aug 29, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric I ZimmermanSharyn D Baker
Apr 10, 2013·Journal of Cancer Research and Clinical Oncology·Nicola PersoneniArmando Santoro
Aug 6, 2014·Nature Reviews. Clinical Oncology·Alejandro FornerJean-Luc Raoul
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Apr 22, 2015·Oncotarget·Xiufeng JiangTong Wang
Citations
Nov 4, 2016·Applied Microbiology and Biotechnology·Shanshan JiangLi Ye
May 4, 2017·Journal of Pharmaceutical Sciences·Nilay ThakkarKim L R Brouwer
Feb 22, 2018·Pathology Oncology Research : POR·Cinthya Santos CirqueiraVenâncio Avancini Ferreira Alves
Jan 6, 2018·Current Medicinal Chemistry·María Paula CeballosMaría Laura Ruiz
Jun 12, 2019·Expert Opinion on Drug Metabolism & Toxicology·Oscar BrizJose J G Marin
Sep 6, 2019·Pharmacogenomics·Marta Alonso-PeñaJose Jg Marin
Apr 1, 2017·Pharmacogenetics and Genomics·Li GongTeri E Klein
Feb 9, 2017·Oncotarget·Andreas GeierJose J G Marin
Nov 5, 2017·Oncotarget·Stephen L AbramsJames A McCubrey
Aug 6, 2016·Oncotarget·Ayman A M AlameenLuca M Neri
Jul 10, 2018·Oncotarget·Rocio I R MaciasOscar Briz
Jun 27, 2020·Cancers·Jose J G MarinOscar Briz
Jul 14, 2020·Oncotarget·Tetsu TomonariTetsuji Takayama
Jul 28, 2019·Clinical Pharmacology and Therapeutics·Mingqing ChenAnne T Nies
Feb 27, 2020·Cells·Jose J G MarinElisa Lozano
Jan 20, 2019·Archives of Toxicology·Silvia Di GiacomoJose J G Marin
Jun 11, 2020·Therapeutic Advances in Medical Oncology·Guanghan FanXiao Xu
Apr 7, 2017·Digestion·Tatsuya TaniguchiTetsuji Takayama
May 6, 2020·International Journal of Molecular Sciences·Maria KrchniakovaRenata Veselska
Oct 15, 2019·Frontiers in Nutrition·Marius FarcasIoana Berindan-Neagoe
Jul 2, 2020·Cancer Management and Research·Kija MalaleZhechuan Mei
Mar 20, 2020·Open Medicine·Ninzi TianMengsu Zeng
Oct 7, 2020·Cancers·Christo KoleDimitrios Schizas
Nov 22, 2020·European Journal of Pharmacology·María Paula CeballosMaría Cristina Carrillo
Apr 14, 2021·Current Drug Targets·Maria Manuela EstevinhoJoão Carvalho